Some patients tolerate one better than the other, and your BelloBella clinician can help navigate this based on your medical history and risk factors
For patients on broader longevity or optimization protocols, GHK-Cu injections may also be combined with NAD+ therapy, BPC-157, or other peptides depending on their clinical goals
You may be a candidate if you have: A body mass index (BMI) of 30 or higher A BMI of 27 or higher with weight-related health problems like high blood pressure or type 2 diabetes Difficulty losing weight through diet and exercise alone Your family doctor in Irving, TX, will evaluate your complete medical history before recommending either medication
Studies have shown a decrease in the risk of major adverse cardiovascular events, a critical consideration for people with diabetes who are at increased risk for heart conditions
Preliminary studies have explored particles that shift from a negative to a positive charge upon permeating the barrier, facilitated by intestinal alkaline phosphatase cleavage of phosphate residues